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Computer-aided detection (CAD) for breast
MRI: evaluation of efficacy at 3.0 T
Abstract Objective: The purpose of
the study was to evaluate the accuracy
of 3.0-T breast MRI interpretation
using manual and fully automated
kinetic analyses. Material and
methods: Manual MRI interpretation
was done on an Advantage Worksta-
tion. Retrospectively, all examinations
were processed with a computer-aided
detection(CAD)system.CADdatasets
were interpreted by two experienced
breast radiologists and two residents.
For each lesion automated analysis of
enhancement kinetics was evaluated at
50% and 100% thresholds. Forty-nine
malignant and 22 benign lesions were
evaluated. Results: Using threshold
enhancement alone, the sensitivity and
specificity of CAD were 97.9% and
86.4%, respectively, for the 50%
threshold, and 97.9% and 90%,
respectively, for the 100% threshold.
Manual interpretation by two breast
radiologists showed a sensitivity of
84.6% and a specificity of 68.8%. For
the same two radiologists the mean
sensitivity and specificity for
CAD-based interpretation was 90.4%
(not significant) and 81.3% (significant
at p<0.05), respectively. With one-way
ANOVA no significant differences
were found between the two breast
radiologists and the two residents
together, or between any two readers
separately. Conclusion: CAD-based
analysis improved the specificity
compared with manual analysis of
enhancement. Automated analysis at
50% and 100% thresholds showed
a high sensitivity and specificity
for readers with varying levels of
experience.
Keywords Breast . Magnetic
resonance imaging . Diagnosis .
Computer-assisted detection .
High field . Neoplasm
Abbreviations MRI: magnetic
resonance imaging . BI-RADS: Breast
Imaging Reporting and Data System .
DCIS: ductal carcinoma in situ . CAD:
computer-aided detection
Introduction
The use of MRI for the detection and evaluation of breast
lesions continues to increase. With a sensitivity of around
90% it is a more sensitive method than conventional
mammography or ultrasound for the detection of breast
cancer [1]. A recent meta-analysis showed the pooled-
weighted specificity to be 72%, with a 95% confidence
interval of 67–77% [1]. An added drawback of breast MRI
is the significant time needed for image processing and
interpretation. Also, the experience level and number of
radiologists trained in breast MRI is not yet as high as for
conventional mammography. Computer-aided detection
(CAD) algorithms have been developed that automate
processing and analysis functions usually performed
manually by MRI technologists and radiologists. These
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Fax: +31-26-3787381systems have the potential to improve efficiency of breast
MRI and to reduce the number of false-positive diagnoses
[2]. Automation may improve consistency and detection
rate, but also provides new analysis methods, such as
kinetic curve threshold, that are not available with manual
interpretation.
Compared with 1.5 T, current MRI systems operating at
3.0 T offer a higher signal-to-noise ratio and allow higher
spatial resolution imaging without affecting overall image
acquisition time or the temporal resolution of the dynamic
contrast-enhanced series [3].
This study was performed to compare the consistency
and accuracy of 3.0-T breast MRI interpretation, between
manual and fully automated kinetic analyses.
Materials and methods
Retrospective inclusion of patients and lesions
We retrospectively analysed the data from a total of 426
consecutive women who underwent contrast-enhanced
high-spatial-resolution 3.0-T breast MRI at our hospital,
between May 2005 and December 2006. We chose this
time period because at that time our hospital replaced the
manual kinetic analysis system with a fully automated
computer-aided detection (CAD)-based kinetic analysis. In
this way, the data from all patients included in this study
were analysed on both systems. No approval by the ethics
board or informed consent was needed because breast MRI
was not performed in a study setting, but in the clinical
setting.
Women who underwent breast MRI not for clinical
indications but for research purposes were excluded from
this study (n=71). In addition, 286 patients were excluded
because histology was not obtained. Of the 69 patients in
whom histology was obtained, 4 patients with 5 lesions
were excluded for technical reasons: severe patient motion
(n=2), failed fat suppression (n=1) and a technical error
with contrast material injection (n=2), which caused an
incomplete study. Finally 65 patients were included with a
total of71breast lesionsprovensurgicallyorby corebiopsy.
The evaluation of the accuracy of CAD threshold enhance-
ment was based on these 65 patients. The evaluation of the
diagnostic accuracy of the four different readers was based
on the same data set, with the exclusion of all 29 BI-RADS
category 6 known cancers. Exclusion of known cancers was
necessary because readers were blinded to the pathological
results but not to patient history (Fig. 1).
Breast MRI: technique
MRI was performed on a 3.0-T MR system (Achieva,
Philips Medical Systems, Best, the Netherlands). Patients
were placed in the prone position on a dedicated phased-
array bilateral breast coil (MRI devices, Würzburg,
Germany). Transverse high-resolution T1-weighted fast
field echo (T1-FFE) images were obtained (TE/TR
1.7/4.5 ms; inversion delay SPAIR 130 ms; flip angle
10°; FOV 340×340 mm
2, acquired voxel size 0.66 × 0.66 ×
1.6 mm
3, reconstructed voxel size 0.66 × 0.66 × 0.80 mm
3),
followed by transverse T2-weighted fat-suppressed images
(TE/TR 120/9,022 ms; inversion delay SPAIR 125 ms; flip
Fig. 1 Flow chart of patient
inclusion, with reasons for
exclusion and total number
of patients for each analysis
method
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2, acquired voxel size 1.01 ×
1.31 × 2.0 mm
3, reconstructed voxel size 0.66 × 0.66 ×
2.00 mm
3). Dynamic fat-suppressed T1-weighted gradient
echo images were acquired before and immediately after
intravenous administration of 0.1 mmol/kg gadopentate
(Magnevist, Schering, Germany) (TE/TR 1.3/3.4 ms; flip
angle 10°; FOV 320 × 320 mm
2, acquired voxel size
0.91 × 0.91 × 2.00 mm
3, reconstructed voxel size 0.83 ×
0.83 × 1.00 mm
3; temporal resolution of 60 s per
dynamic acquisition, with a total of 6 dynamic acquisi-
tions; finally, a post-gadolinium T1-weighted gradient
echo series (TE/TR 1.7/4.5 ms; inversion delay SPAIR
130 ms; flip angle 10°; FOV 340×340 mm
2, acquired
voxel size 0.66 × 0.66 × 1.60 mm
3, reconstructed voxel
size 0.66 × 0.66 × 0.80 mm
3).
Breast MRI interpretation and data collection
Breast MR interpretation using manual kinetics analysis
was done on an Advantage Workstation (Philips View-
forum, Best, the Netherlands), which allows assessment of
enhancement kinetics by manual region-of-interest (ROI)
placement. Studies were read by one of two experienced
breast radiologists who were blinded to the pathological
results. For each MRI-detected lesion, a separate American
College of Radiology (ACR) BI-RADS-MRI Lexicon
Classification Form [4] was filled out. In addition, for each
lesion the maximum size in two orthogonal directions was
measured.
All MRI examinations were subsequently processed by
CADstream (Confirma, Inc., Kirkland, WA), a commer-
cially available computer-aided detection system. With
CADstream, areas of enhancement that meet a user-
defined minimum threshold for initial enhancement are
automatically identified by colour overlays on all MRI
slices. This initial enhancement threshold refers to the
minimum increase in signal intensity on the early post-
contrast-images over the pre-contrast images, within
the same dynamic series. In addition to indicating the
degree of initial enhancement, the colour overlay allows
differentiation between persistent-, plateau- and washout-
type enhancement in the late phase after contrast
injection.
CADstream data sets were interpreted by the same two
breast radiologists. In addition the data sets were
interpreted by two residents. The two breast radiologists
are both registered breast radiologists and have more then
15 years’ experience in breast ultrasound and conventional
mammography. Both radiologist also have more then
5y e a r s ’ experience in breast MRI. The first residents was
in his third year and had 6 months’ experience in
conventional mammography, breast ultrasound and breast
MRI, by the time this study took place in our hospital.
The second resident was in her first year and only had
2 months of experience in conventional mammography
and breast ultrasound. She had only little experience in
breast MRI, by following a 4-day course in breast MRI.
All of the readers were blinded to the patient’sh i s t o r y ,
treatment and pathological outcome, and to the results of
the initial interpretation using manual enhancement
kinetics. CAD reading was done 6 months after manual
analysis of the same data set. The interval was felt to be
long enough to prevent the readers from remembering the
details of the initial manual kinetic analysis. All readers
were familiar with the BI-RADS classification system.
Separate BI-RADS-MRI score sheets were again filled
out for all MRI-detected lesions, by all individual
readers.
Lastly, lesions were scored based on CAD threshold
analysis alone, first on the basis of a 50% threshold of
initial enhancement and subsequently on the basis of a
100% threshold of initial enhancement.
Statistical analysis
Statistical analysis was done with SPSS 12.0. Significance
was assumed at a level of p<0.05. The interobserver
differences in the evaluation of quality criteria were
evaluated by the paired Student’s t test. One-way analysis
ofvariance(ANOVA)wasusedtotestfordifferencesamong
the two experienced breast radiologistsandthe two residents
together, or between any two readers separately with the use
of CAD.
According to the American College of Radiology ACR
guidelines, which suggest follow-up for “probably benign”
lesions (BI-RADS category 3) and consideration of biopsy
for “suspicious” lesions (BI-RADS category 4), sensitivity
and specificity according to BI-RADS score were defined
as follows:
Sensitivity BI   RADS ¼
Numbers of PA proven malignant lesions with BI RADS score 4 or 5
Number of PA proven malignant lesions
Specificity BI   RADS ¼
Numbers of PA proven benign lesions with BI RADS rating   3
Number of PA proven benign lesions
where PA refers to pathology.
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Patients and lesions
The mean age of the included patients was 49 years (range,
29–71 years). Indications for undergoing MRI (Table 1)
were: evaluation of indeterminate mammographic and/or
ultrasound findings (46%); staging of recently diagnosed
breast cancer (45%); and high-risk screening (20%). Five
patients had two indications and one patient had three
indications.
Lesion characteristics
Lesions consisted of a focal (8.5%), mass (77.7%), or non-
mass-like enhancement (13.8%). Size ranged from 4 to
49 mm. Histopathological evaluation after core-needle
biopsy or surgical excision revealed 22 benign (including
high-risk) lesions and 49 malignant lesions. Of the 22
benign lesions, 9 (13%) were fibroadenoma, 6 (8%)
showed focal fibrocystic change, 1 (1%) was a benign
complex cyst, 1 (1%) was a lymph node, and 5 (7%) were
lobular carcinoma in situ (LCIS) (Table 2).
Of the 49 malignant lesions, 24 (34%) were invasive
carcinoma (15 invasive ductal carcinoma, 7 invasive
lobular carcinoma and 2 invasive ducto-lobular carcino-
ma), 7 (10%) were pure ductal carcinoma in situ (DCIS),
14 (20%) were a combination of in situ and infiltrating
carcinoma, and 4 separate lesions in a single patient turned
out to be metastases from small cell lung cancer (Table 2).
Table 3 summarises the sensitivity and specificity for
interpretation with manual analysis of enhancement kinet-
ics and for interpretation with CAD-based analysis
enhancement kinetics. Sensitivity and specificity based
on CAD threshold analysis alone are summarised in
Table 4.
Manual interpretation showed a sensitivity of 84.6% and
a specificity of 68.8%. For the same two radiologists the
mean sensitivity and specificity for CAD-based interpre-
tation was 90.4% and 81.3%, respectively. This difference
in specificity was significant at p<0.05. Between all four
CAD readers the sensitivity varied from 84.6% to 92.3%
and the specificity varied from 75.0% to 81.3%. By one-
way ANOVA no statistical significant difference was found
in our study between the two experienced breast radiologists
and the two residents together, or between any two readers
separately with the use of CAD (Table 3).
Using threshold enhancement alone, the sensitivity and
specificity of CAD were 97.9% and 86.4% for the 50%
threshold, respectively, and 97.9% and 90% for the 100%
threshold, respectively (Fig. 2 and Table 4).
Table 1 Indication for MRI examination in 65 patients
Number
High-risk screening 13 (20%)
Positive family history 7
History of high-risk lesion or cancer 6
Problem solving 30 (46.2%)
Palpable abnormality 6
Questionable lesion mammogram/US 23
Positive axillary node, unknown primary 1
Staging of known breast cancer 29 (44.6%)
Table 2 Histopathologic findings in 71 breast lesions
Number
Malignant lesions 49 (69%)
Invasive ductal carcinoma 15
Infiltrating lobular carcinoma 7
Invasive ducto-lobular carcinoma 2
Pure ductal carcinoma in situ (DCIS) 7
Combination of DCIS and invasive carcinoma 14
Small cell carcinoma 4
High-risk lesions 5 (7%)
Lobular carcinoma in situ 5
Benign lesions 17 (23.9%)
Fibrocystic change 6
Fibroadenoma 9
Lymph node 1
Benign cyst 1
Total 71
Table 3 Sensitivity and specificity of 42 lesions (benign n=16,
malignant n=26)
Sensitivity Specificity
Radiologist; manual 84.6% (n=22) 68.8% (n=11)
Radiologist 1; CAD 88.5% (n=23) 75.0% (n=12)
Radiologist 2; CAD 92.3% (n=24) 87.5% (n=14)
Residents 1; CAD 88.5% (n=23) 93.8% (n=15)
Resident 2; CAD 84.6% (n=22) 81.3% (n=13)
Table 4 Sensitivity and specificity of 71 lesions at threshold
enhancement at 50% and 100% (benign n=22, malignant n=49)
Sensitivity Specificity
CAD 50% 97.9% 86.4%
CAD 100% 97.9% 90.0%
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We found that interpretation with CAD-based analysis for
enhancement kinetics significantly improved the discrim-
ination of benign from malignant lesions compared with
interpretation with manual analysis of enhancement kinet-
ics. In our study initial enhancement was below 50% in
86% of benign lesions. These results are in keeping with
the findings of Williams et al. [5]. Other authors also
described an increase in specificity of using CAD that is
based on excluding lesions with low threshold enhance-
ment [6–11].
Difference in specificity between MR interpretation on
an Advantage Workstation with manual assessment of
enhancement kinetics and CAD may also partly be
explained by the fact that CAD provides enhancement
information for all pixels in a lesion rather than for a
portion of a lesion measured by using manual region-of-
interest placement [5].
Using threshold enhancement alone, the sensitivity of
CAD is high for both the 50% threshold and 100%
threshold. There was only one malignant lesion that was
false negative at CAD and did not demonstrate enhance-
ment at the 50% and 100% thresholds. This lesion was
described by three readers as a lobular-shaped mass with
irregular margin and heterogeneous enhancement. One
reader described this lesion as a round-shaped mass with
regular margin and heterogeneous enhancement. Placing a
manual ROI showed a malignant curve (Fig. 3). Three out
of the four readers classified this lesion as a BI-RADS 5
lesion, highly suggestive of malignancy, and one reader
as a BI-RADS 4 lesion, suspicious. Histopathological
evaluation revealed an invasive ductal carcinoma. There
are some technical limitations to the CAD program that
can cause negative enhancement at malignant lesions
which underscore the importance of using CAD as a
complement to but not as a replacement for the
radiologist’s assessment [5].
Three benign lesions had positive enhancement at a 50%
threshold and two of these lesions had positive enhance-
ment at 100%. The lesion that had positive enhancement at
50% threshold and negative enhancement at 100% thresh-
Lesions  
N=71 
 
Benign = 22 
Malignant = 49
Negative 
Enhancement at 50% 
Threshold 
N = 20 
Benign = 19 
Malignant = 1 
Positive 
Enhancement at 50% 
Threshold 
N = 51 
Benign = 3 
Malignant = 48 
Negative 
Enhancement at 
100% Threshold 
N = 21 
Benign = 20 
Malignant = 1 
Positive 
Enhancement at 
100% Threshold 
N = 50 
Benign = 2 
Malignant = 48 
Fig. 2 Flow chart of threshold
enhancement at 50% and 100%
Fig. 3 Example of a lesion that
was not colour-coded by CAD
as possibly malignant, because
the absolute pre-contrast signal
intensity was determined to be
“too low”. Manual analysis
revealed a washout-type curve
for this lesion, with positive
threshold-enhancement at both
50% and 100%. Pathology
showed an invasive ductal
carcinoma
526old consisted of normal tissue at histopathological evalua-
tion. Two readers classified this lesion as a BI-RADS 3
lesion, probably benign (one resident and one radiologist),
and the other two readers classified this lesion as a BI-
RADS 2 lesion, benign. The two false-positive lesions with
positive enhancement at the 50% and 100% thresholds
revealed one lobular carcinoma in situ and one fibroade-
noma. Two readers classified the fibroadenoma (Fig. 4)a sa
BI-RADS 3 lesion, one as a BI-RADS 2 lesion and one as
an BI-RADS 4 lesion. Lobular carcinoma in situ (Fig. 5), a
high-risk lesion, was twice classified as a BI-RADS 3
lesion and twice as a BI-RADS 4 lesion.
In our study the readers were not blinded to the results of
other imaging examinations such as mammography, ultra-
sound and previous MRI findings. All readers had access to
patient history and clinical information, i.e. similar to the
normal clinical setting. In the study by Kurz et al. who
compared three different software systems in the evaluation
of breast MRI, all three investigators were blinded to this
information [10].
Our study had several limitations. Time needed to fully
assess one MRI examination of the breast was not
objectified as in the study of Kurz et al. [10]. They
describe an average time needed to evaluate each exam of
7.0 min. Wiener et al. reported that most cases were
interpreted with the use of an automatic post-processing
program which generated colour parametric maps as well
in less than 5 min [9]. Although not objectified, the two
breast radiologists reported shorter interpretation times
with CAD assistance than with manual analysis.
Another limitation is that manual interpretation was not
repeated by the two residents. Meinel et al. showed that
inexperienced readers without the use of CAD assistance
performed as expected for their level of experience and that
these differences became less pronounced with the use of
CAD assistance [11]. In our study, no significant differ-
ences were found between the two experienced breast
radiologists and the two residents together, or between any
two readers separately with the use of CAD.
With respect to interpreting the very high sensitivities
reported here for CAD-based analysis based solely on the
thresholding of enhancement kinetics, it should be noted
that a selection bias was introduced by only including data
from patients with lesions proven by core or excision
biopsy.
In summary, our findings suggest that CAD has the
potential to improve the discrimination of benign from
Fig. 4 Example of a false-
positive finding. CAD analysis
of this lesion (the lesion in red
and yellow on the left image)
indicated positive enhancement
at the 50% and 100% thresh-
olds. The image on the right is
the same lesion in the same slice
without the colour-coded
overlay. Pathology revealed a
benign fibroadenoma
Fig. 5 Example of a false-positive finding. CAD analysis of this
lesion (the yellow lesion in the right breast) indicated positive
enhancement at the 50% and 100% thresholds. Pathology revealed a
lobular carcinoma in situ, a high-risk lesion
527malignant breast lesions at 3.0-T MRI. Additionally CAD
may decrease the heterogeneity of interpretation across
radiologists of varying levels of experience in breast MR
interpretation.
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